They're looking for G1 treatment failures for the 034 trial - if...

They're looking for G1 treatment failures for the 034 trial - if a patient has done a treatment course of 48 weeks PEG/riba then they're probably a good trial candidate as it's very exacting. However, at Duke there will be access to trials of polymerase and protease inhibitors as well (McHutchison who ran the unit there was one of the go-to guys for HCV trials before being poached by Gilead), many competing for the same patients. When faced with the choice of an 8-12 week trial with medications with little or no side effects and a track record of 90%+ cure, and a brand new treatment never used before in humans (no track record), then you can see recruitment might be slow.